Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome

Bone Marrow Transplantation volume 44, pages 441–447 (2009)Cite this article

Abstract

Hepatic complications of transplant are a common cause of mortality. Although mild elevations of serum aminotransferase enzymes (aspartate and alanine (AST, ALT)) do not carry an adverse prognosis, this is not the case with severe hepatocellular injury. We reviewed 6225 consecutive recipients to determine the incidence and outcomes of severe hepatocellular injury (AST >1500 U/l) before day 100, which occurred in 88 patients. Causes were sinusoidal obstruction syndrome (SOS) (n=46), hypoxic hepatitis (n=33), varicella zoster virus (VZV) hepatitis (n=4), drug-liver injury (n=2) and unknown (n=3). The incidence declined from 1.9% in the 1990s to 1.1% recently (owing to a fivefold decline in SOS and disappearance of VZV hepatitis). In hypoxic hepatitis, peak serum AST was 3545 U/l (range, 1380–25 246) within days of shock or prolonged hypoxemia; case fatality rate was 88%. In SOS, AST increases occurred 2–6 weeks after diagnosis; peak AST was 2252 U/l (range, 1437–8281); case fatality rate was 76%, with only serum bilirubin able to distinguish survivors (2.7 vs 11.3 mg/100 ml, P=0.0009). We conclude that circulatory insults (sinusoidal injury, hypotension and hypoxemia), and not infection, are the most common cause of severe hepatocellular injury, the frequency of which has declined because of a falling incidence of SOS and VZV hepatitis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Strasser SI, McDonald GB . Gastrointestinal and hepatic complications. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG (eds). Thomas' Hematopoietic Cell Transplantation, 4th edn. Wiley-Blackwell Publishing: Oxford, UK, 2009, pp 1434–1455.

    Chapter  Google Scholar 

  2. Gooley TA, Rajvanshi P, Schoch HG, McDonald GB . Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation. Hepatology 2005; 41: 345–352.

    Article  CAS  PubMed  Google Scholar 

  3. El-Sayed MH, El-Haddad A, Fahmy OA, Salama II, Mahmoud HK . Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation. Eur J Gastroenterol Hepatol 2004; 16: 1347–1354.

    Article  PubMed  Google Scholar 

  4. Kim B, Chung K, Sun H, Suh J, Min W, Kang C et al. Liver disease during the first posttransplant year in bone marrow transplantation recipients: retrospective study. Bone Marrow Transplant 2000; 26: 193–197.

    Article  CAS  PubMed  Google Scholar 

  5. McDonald GB . Management of hepatic disease following hematopoietic cell transplant. Alimentary Pharmacol Ther 2006; 24: 441–452.

    Article  CAS  Google Scholar 

  6. Shulman HM, McDonald GB . Hepatic complications of hematopoietic cell transplantation. In: Gershwin ME, Vierling JM, Manns M (eds). Liver Immunology: Principles and Practice. Humana Press: Totowa, NJ, 2007, pp 409–421.

    Chapter  Google Scholar 

  7. Strasser SI, Myerson D, Spurgeon CL, Sullivan KM, Storer B, Schoch HG et al. Hepatitis C virus infection after bone marrow transplantation: a cohort study with 10 year follow-up. Hepatology 1999; 29: 1893–1899.

    Article  CAS  PubMed  Google Scholar 

  8. Ruutu T, Eriksson B, Remes K, Juvonen E, Volin L, Remberger M et al. Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood 2002; 100: 1977–1983.

    Article  CAS  PubMed  Google Scholar 

  9. Ho G-T, Parker A, MacKenzie JF, Morris AJ, Stanley AJ . Abnormal liver function tests following bone marrow transplantation: aetiology and role of liver biopsy. Eur J Gastroenterol Hepatol 2004; 16: 157–162.

    Article  PubMed  Google Scholar 

  10. Sucak G, Yegin Z, Ozkurt Z, Aki S, Karakan T, Akyol G . The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated? Bone Marrow Transplant 2008; 42: 461–467.

    Article  CAS  PubMed  Google Scholar 

  11. Lau GKK, Strasser SI, McDonald GB . Hepatitis virus infections in patients with cancer. In: Wingard JR, Bowden RA (eds). Management of Infection in Oncology Patients. Martin Dunitz: London, UK, 2003, pp 321–342.

    Chapter  Google Scholar 

  12. Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller FR . Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine 2003; 82: 392–406.

    Article  PubMed  Google Scholar 

  13. Deleve LD, Shulman HM, McDonald GB . Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (venocclusive disease). Semin Liver Dis 2002; 22: 27–41.

    Article  PubMed  Google Scholar 

  14. Kaplowitz N, DeLeve LD (eds). Drug Induced Liver Disease, 2nd edn. Informa Healthcare USA, Inc.: New York, 2007.

    Book  Google Scholar 

  15. Strasser SI, Shulman HM, McDonald GB . Cholestasis after hematopoietic cell transplantation. Clin Liver Dis 1999; 3: 651–668.

    Article  CAS  PubMed  Google Scholar 

  16. Rossi MR, Longoni DV, Rovelli AM, Uderzo C . Severe rhabdomyolysis, hyperthermia and shock after amphotericin B colloidal dispersion in an allogeneic bone marrow transplant recipient. Pediatr Infect Dis J 2000; 19: 172–173.

    Article  CAS  PubMed  Google Scholar 

  17. Tong J, Laport G, Lowsky R . Rhabdomyolysis after concomitant use of cyclosporine and simvastatin in a patient transplanted for multiple myeloma. Bone Marrow Transplant 2005; 36: 739–740.

    Article  CAS  PubMed  Google Scholar 

  18. Rajvanshi P, Shulman HM, Sievers EL, McDonald GB . Hepatic sinusoidal obstruction following Gemtuzumab ozogamicin (Mylotarg) therapy. Blood 2002; 99: 4245–4246.

    Article  Google Scholar 

  19. McDonald GB, Hinds MS, Fisher LB, Schoch HG, Wolford JL, Banaji M et al. Venocclusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255–267.

    Article  CAS  PubMed  Google Scholar 

  20. Fischer MA, Winkelmayer WC, Rubin RH, Avorn J . The hepatotoxicity of antifungal medications in bone marrow transplant recipients. Clin Infect Dis 2005; 41: 301–307.

    Article  CAS  PubMed  Google Scholar 

  21. Honjo I, Suou T, Hirayama C . Hepatotoxicity of cyclophosphamide in man: pharmacokinetic analysis. Res Commun Chem Pathol Pharmacol 1988; 61: 149–165.

    CAS  PubMed  Google Scholar 

  22. Gnann J . Herpes simplex and varicella zoster virus infection after hemopoietic stem cell or solid organ transplantation. In: Bowden RA, Ljungman P, Paya CV (eds). Transplant Infections. 2nd edn. Lippincott Williams and Wilkins: Philadelphia, 2003, pp 350–366.

    Google Scholar 

  23. Shields AF, Hackman RC, Fife KH, Corey L, Meyer JD . Adenovirus infections in patients undergoing bone marrow transplantation. N Engl J Med 1985; 312: 529–533.

    Article  CAS  PubMed  Google Scholar 

  24. Neofytos D, Ojha A, Mookerjee B, Wagner J, Filicko J, Ferber A et al. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant 2007; 13: 74–81.

    Article  CAS  PubMed  Google Scholar 

  25. Wang WH, Wang HL . Fulminant adenovirus hepatitis following bone marrow transplantation. A case report and brief review of the literature. Arch Pathol Lab Med 2003; 127: e246–e248.

    PubMed  Google Scholar 

  26. Strasser SI, Shulman HM, Flowers ME, Reddy R, Margolis DA, Prumbaum M et al. Chronic graft-vs-host disease of the liver: presentation as an acute hepatitis. Hepatology 2000; 32: 1265–1271.

    Article  CAS  PubMed  Google Scholar 

  27. Akpek G, Boitnott JK, Lee LA, Hallick JP, Torbenson M, Jacobsohn DA et al. Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion. Blood 2002; 100: 3903–3907.

    Article  CAS  PubMed  Google Scholar 

  28. Sakai M, McDonald GB . Gastrointestinal and hepatic manifestations of chronic GVHD. In: Vogelsang G, Pavletic S (eds). Chronic Graft-Versus-Host Disease: Interdisciplinary Management. Cambridge University Press: New York, NY, 2009, pp 216–228.

    Chapter  Google Scholar 

  29. Shulman HM, Fisher LB, Schoch HG, Henne KW, McDonald GB . Venocclusive disease of the liver after marrow transplantation: histologic correlates of clinical signs and symptoms. Hepatology 1994; 19: 1171–1180.

    Article  CAS  PubMed  Google Scholar 

  30. Traber PG, Chianale J, Gumucio JJ . Physiologic significance and regulation of hepatocellular heterogeneity. Gastroenterology 1988; 95: 1130–1143.

    Article  CAS  PubMed  Google Scholar 

  31. McKoy JM, Angelotta C, Bennett CL, Tallman MS, Wadleigh M, Evens AM et al. Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project. Leuk Res 2007; 31: 599–604.

    Article  CAS  PubMed  Google Scholar 

  32. McDonald GB, Frieze D . A problem-oriented approach to liver disease in oncology patients. Gut 2008; 57: 987–1003.

    Article  CAS  PubMed  Google Scholar 

  33. McDonald GB, Schoch H, Gooley T . Liver complications of allogeneic hematopoietic cell transplant: declining incidence related to changes in practice (Abstract). Hepatology 2008; 48 (Suppl): 318A–319A.

    Google Scholar 

Download references

Acknowledgements

Our research in the field of gastrointestinal and hepatobiliary complications of hematopoietic cell transplant is supported by grants from the US National Institutes of Health, National Cancer Institute (CA 18029, CA 15704). Dr Sakai is supported by funding from the Bureau of Social Welfare and Public Health of the Tokyo Metropolitan Government and the Japan Clinical Research Support Unit.

Author information

Authors and Affiliations

  1. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

    M Sakai, H M Shulman, S J McDonald, H G Schoch & G B McDonald

  2. AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia

    S I Strasser

  3. Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA

    H M Shulman & G B McDonald

Authors
  1. M Sakai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S I Strasser
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H M Shulman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S J McDonald
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H G Schoch
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G B McDonald
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sakai, M., Strasser, S., Shulman, H. et al. Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome. Bone Marrow Transplant 44, 441–447 (2009). https://doi.org/10.1038/bmt.2009.56

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2009.56

Keywords

This article is cited by

Search

Advanced search

Quick links